Megan covers the intersection of science and society. How is biomedical research funded? Who benefits? And how do new technologies reflect and shape our values? You can reach Megan on Signal at ...
Let's be honest, we're all drama queens sometimes. Whether you're texting your bestie you're “literally dying” over the latest celebrity gossip or declaring on social media that Monday mornings are ...
A rare clinical phenomenon has been reported. Patients with pulmonary adenocarcinoma consulted the neurology department due to multiple initial symptoms of cerebral ischaemia. Examination of each ...
NEW ORLEANS -- Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, raising its prospects as an investigational neuroprotective therapy. In ...
Initiation of the multi-target anti-neuroinflammatory drug minocycline within 72 hours of acute ischemic stroke had a significant benefit in functional outcome compared to placebo, with no increased ...
In 2025, more than 3,800 research grants from the National Institutes of Health and the National Science Foundation were terminated or frozen as part of the Trump administration’s effort to realign ...
Scientists at EPFL have developed an innovative, non-invasive brain stimulation therapy to significantly improve visual function in stroke patients who have suffered vision loss following a stroke.
Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the "vertical midline"). Hemianopia severely affects daily activities ...
Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the “vertical midline”). Hemianopia severely affects daily activities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results